Andrew Hirsch, C4 Therapeutics CEO
Andrew Hirsch lines up a chunk of equity in his new job as C4 spells out development plans in IPO
Andrew Hirsch’s first job as the newly-minted CEO of C4 Therapeutics was already fully spelled out ahead of his arrival.
On Thursday, the biotech jumped …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
